JPMorgan Chase & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183M | Buy |
|
|||||
|
2025
Q1 | $206M | Buy |
|
|||||
|
2024
Q4 | $196M | Buy |
|
|||||
|
2024
Q3 | $169M | Sell |
|
|||||
|
2024
Q2 | $164M | Buy |
|
|||||
|
2024
Q1 | $180M | Buy |
|
|||||
|
2023
Q4 | $172M | Sell |
|
|||||
|
2023
Q3 | $185M | Sell |
|
|||||
|
2023
Q2 | $210M | Sell |
|
|||||
|
2023
Q1 | $311M | Sell |
|
|||||
|
2022
Q4 | $454M | Sell |
|
|||||
|
2022
Q3 | $468M | Buy |
|
|||||
|
2022
Q2 | $527M | Buy |
|
|||||
|
2022
Q1 | $512M | Buy |
|
|||||
|
2021
Q4 | $410M | Buy |
|
|||||
|
2021
Q3 | $377M | Buy |
|
|||||
|
2021
Q2 | $512M | Buy |
|
|||||
|
2021
Q1 | $312M | Sell |
|
|||||
|
2020
Q4 | $314M | Buy |
|
|||||
|
2020
Q3 | $260M | Buy |
|
|||||
|
2020
Q2 | $192M | Sell |
|
|||||
|
2020
Q1 | $176M | Sell |
|
|||||
|
2019
Q4 | $285M | Sell |
|
|||||
|
2019
Q3 | $277M | Sell |
|
|||||
|
2019
Q2 | $311M | Sell |
|
|||||
|
2019
Q1 | $323M | Buy |
|
|||||
|
2018
Q4 | $240M | Buy |
|
|||||
|
2018
Q3 | $321M | Buy |
|
|||||
|
2018
Q2 | $311M | Buy |
|
|||||
|
2018
Q1 | $247M | Buy |
|
|||||
|
2017
Q4 | $204M | Sell |
|
|||||
|
2017
Q3 | $248M | Buy |
|
|||||
|
2017
Q2 | $219M | Buy |
|
|||||
|
2017
Q1 | $144M | Buy |
|
|||||
|
2016
Q4 | $93.1M | Buy |
|
|||||
|
2016
Q3 | $86.8M | Sell |
|
|||||
|
2016
Q2 | $118M | Sell |
|
|||||
|
2016
Q1 | $140M | Buy |
|
|||||
|
2015
Q4 | $126M | Buy |
|
|||||
|
2015
Q3 | $111M | Buy |
|
|||||
|
2015
Q2 | $135M | Buy |
|
|||||
|
2015
Q1 | $126M | Buy |
|
|||||
|
2014
Q4 | $90.8M | Buy |
|
|||||
|
2014
Q3 | $67M | Sell |
|
|||||
|
2014
Q2 | $72.1M | Sell |
|
|||||
|
2014
Q1 | $74.7M | Buy |
|
|||||
|
2013
Q4 | $65.6M | Buy |
|
|||||
|
2013
Q3 | $28.4M | Buy |
|
|||||
|
2013
Q2 | $10.3M | Buy |
|